Get started Log in

NUZ — Neurizon Therapeutics Share News

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Market Cap
AU$62.62m
Enterprise Value
AU$53.22m
Revenue

Brief: Pharmaust Says US FDA Grants Co's Pre-Ind Meeting For Monepantel For Treatment Of MND/ALS
01/01/2024 23:02
Brief: Pharmaust Raises A$3.5 Million At A Premium
13/12/2023 24:52
Brief: Pharmaust Seeks Trading Halt
10/12/2023 22:54
Australia's Pharmaust hits over 4-month high on completion of Phase 1 study
30/11/2023 23:47
Brief: Pharmaust Seeks Trading Halt
05/10/2023 22:58
Brief: Pharmaust Says Michael Thurn Appointed As CEO Effective 1 September
28/08/2023 04:15
Brief: Pharmaust Seeks Trading Halt
17/08/2023 11:18
Brief: Pharmaust Says Epichem Enters Voluntary Liquidation
01/08/2023 02:57
Brief: Pharmaust Seeks Trading Halt
10/07/2023 02:35
Brief: Pharmaust Seeks Trading Halt
30/06/2023 01:31
Australia's Pharmaust rises on progress on Motor Neurone Disease drug trial
27/06/2023 05:57
Brief: Pharmaust Ltd Seeks Trading Halt
05/06/2023 24:37
Australia's PharmAust eyes worst day in over 10 mths on discounted placement
03/05/2023 03:05
Brief: Pharmaust Raises A$2.5M Via Placement
03/05/2023 02:18
Brief: Pharmaust Ltd Seeks Trading Halt
28/04/2023 09:26
Brief: Pharmaust Ltd Commenced Search For A New Australian-Based Chief Executive Officer
13/04/2023 02:10
Australia's PharmAust gains on positive result for its motor neurone disease drug
06/01/2023 24:57
Pharmaust jumps on promising results from motor neurone disease drug trial
02/12/2022 04:47
Brief: Pharmaust Says To Undertake Phase 2 Study In Covid-19 Rather Than A Phase 1 Study
24/05/2022 24:07
Australia Stock Exchange release from PHARMAUST : MPL manufactured and tableting commenced
14/03/2022 21:20